Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways.
Romani C, Lorini L, Bozzola A, Bignotti E, Tomasoni M, Ardighieri L, Bugatti M, Battocchio S, Ravaggi A, Tomasini D, Ravanelli M, Gurizzan C, Lombardi D, Mattavelli D, Calza S, Piazza C, Bossi P. Romani C, et al. Among authors: tomasini d. Sci Rep. 2023 Jan 31;13(1):1809. doi: 10.1038/s41598-023-28901-9. Sci Rep. 2023. PMID: 36720951 Free PMC article.
The role of interventional radiotherapy (brachytherapy) in stage I esophageal cancer: an AIRO (Italian Association of Radiotherapy and Clinical Oncology) systematic review.
Lancellotta V, Cellini F, Fionda B, De Sanctis V, Vidali C, Fusco V, Frassine F, Tomasini D, Vavassori A, Gambacorta MA, Franco P, Genovesi D, Corvò R, Tagliaferri L. Lancellotta V, et al. Among authors: tomasini d. Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7589-7597. doi: 10.26355/eurrev_202007_22257. Eur Rev Med Pharmacol Sci. 2020. PMID: 32744685 Free article.
Gene Expression Profiling of Olfactory Neuroblastoma Helps Identify Prognostic Pathways and Define Potentially Therapeutic Targets.
Romani C, Bignotti E, Mattavelli D, Bozzola A, Lorini L, Tomasoni M, Ardighieri L, Rampinelli V, Paderno A, Battocchio S, Gurizzan C, Castelnuovo P, Turri-Zanoni M, Facco C, Sessa F, Schreiber A, Ferrari M, Ravaggi A, Deganello A, Nicolai P, Buglione M, Tomasini D, Maroldi R, Piazza C, Calza S, Bossi P. Romani C, et al. Among authors: tomasini d. Cancers (Basel). 2021 May 21;13(11):2527. doi: 10.3390/cancers13112527. Cancers (Basel). 2021. PMID: 34064009 Free PMC article.
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma.
Lombardi D, Tomasoni M, Lorini L, Gurizzan C, Tomasini D, Ardighieri L, Battocchio S, Bozzola A, Mattavelli D, Paderno A, Zamparini M, Farina D, Ravanelli M, Maroldi R, Maddalo M, Magrini S, Berruti A, Deganello A, Nicolai P, Bossi P, Piazza C. Lombardi D, et al. Among authors: tomasini d. Oral Oncol. 2022 Mar;126:105764. doi: 10.1016/j.oraloncology.2022.105764. Epub 2022 Feb 11. Oral Oncol. 2022. PMID: 35158286
Treatment of loco-regional recurrence of nasopharyngeal carcinoma in a non-endemic area: oncologic outcomes, morbidity, and proposal of a prognostic nomogram.
Rampinelli V, Ferrari M, Mattavelli D, Bonomo P, Lambertoni A, Turri-Zanoni M, D'Angelo E, Alterio D, Cianchetti M, Vischioni B, Rosati R, Tomasoni M, Alparone M, Taboni S, Tomasini D, Maddalo M, Bastia MBDM, Iacovelli NA, Dionisi F, Bignami M, Battaglia P, Bossi P, Deganello A, Piazza C, Schreiber A, Nicolai P, Castelnuovo P, Orlandi E. Rampinelli V, et al. Among authors: tomasini d. Front Oncol. 2023 May 16;13:1157584. doi: 10.3389/fonc.2023.1157584. eCollection 2023. Front Oncol. 2023. PMID: 37260976 Free PMC article.
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group.
Bardoscia L, Triggiani L, Sandri M, Francavilla S, Borghetti P, Dalla Volta A, Veccia A, Tomasini D, Buglione M, Valcamonico F, Simeone C, Berruti A, Magrini SM, Antonelli A. Bardoscia L, et al. Among authors: tomasini d. World J Urol. 2021 Apr;39(4):1161-1170. doi: 10.1007/s00345-020-03315-8. Epub 2020 Jun 26. World J Urol. 2021. PMID: 32591899
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience.
Borghetti P, Volpi G, Facheris G, Cossali G, Mataj E, La Mattina S, Singh N, Imbrescia J, Bonù ML, Tomasini D, Vitali P, Greco D, Bezzi M, Melotti F, Benvenuti M, Borghesi A, Grisanti S, Buglione di Monale E Bastia M. Borghetti P, et al. Among authors: tomasini d. Front Oncol. 2023 Jul 4;13:1208204. doi: 10.3389/fonc.2023.1208204. eCollection 2023. Front Oncol. 2023. PMID: 37469420 Free PMC article.
69 results